Filing Details

Accession Number:
0001493152-22-018830
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-07 17:18:01
Reporting Period:
2022-07-05
Accepted Time:
2022-07-07 17:18:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
714256 Sanara Medtech Inc. SMTI Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 592220004
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1799602 B. Zachary Fleming 1200 Summit Ave
Suite 414
Fort Worth TX 76102
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-07-05 265 $21.45 38,685 No 4 S Direct
Common Stock Disposition 2022-07-06 665 $22.00 38,020 No 4 S Direct
Common Stock Disposition 2022-07-06 750 $23.00 37,270 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $22.00, inclusive. The reporting person undertakes to provide to Sanara MedTech Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.